The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer

Background: The oncoprotein-18/stathmin 1 (STMN1), involved in cell progression and migration, is associated with clinical outcome in breast cancer. Here we aim to investigate its clinical significance in urinary bladder cancer and its possibilities as a therapeutic target. Methods: Immunohistochemi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2014-09, Vol.111 (6), p.1180-1187
Hauptverfasser:	Hemdan, T, Lindén, M, B Lind, S, V Namuduri, A, Sjöstedt, E, D de Ståhl, T, Asplund, A, Malmström, P-U, Segersten, U
Format:	Artikel
Sprache:	eng
Schlagworte:	692/53/2422 692/699/67/1059/602 692/699/67/589/1336 Biological and medical sciences Biomedical and Life Sciences Biomedicine Bladder cancer Cancer Research Carcinoma, Transitional Cell - drug therapy Carcinoma, Transitional Cell - metabolism Carcinoma, Transitional Cell - secondary Cell Line, Tumor Cell Movement Cell Proliferation Drug Resistance Epidemiology Female Gene Silencing Humans Kaplan-Meier Estimate Ki-67 Antigen - analysis Male Medical sciences Molecular Medicine Molecular Targeted Therapy Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Neoplasm Invasiveness Neoplasm Staging Nephrology. Urinary tract diseases Oncology Prognosis Stathmin - genetics Stathmin - metabolism Tissue Array Analysis Translational Therapeutics Tumor Suppressor Protein p53 - analysis Tumors Tumors of the urinary system Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - metabolism Urinary Bladder Neoplasms - pathology Urinary tract. Prostate gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!